Actinium Pharmaceuticals Inc banner
A

Actinium Pharmaceuticals Inc
AMEX:ATNM

Watchlist Manager
Actinium Pharmaceuticals Inc
AMEX:ATNM
Watchlist
Price: 1.11 USD -1.77% Market Closed
Market Cap: $34.6m

Profitability Summary

Actinium Pharmaceuticals Inc's profitability score is 43/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

43/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

43/100
Profitability
Score
43/100
Profitability
Score

Margins

Earnings Waterfall
Actinium Pharmaceuticals Inc

Margins Comparison
Actinium Pharmaceuticals Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Actinium Pharmaceuticals Inc
AMEX:ATNM
34.6m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
388.4B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.4B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
179.9B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.2B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.8B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
68B AUD
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
37.8B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Actinium Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Actinium Pharmaceuticals Inc
AMEX:ATNM
34.6m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
388.4B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.4B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
179.9B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.2B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.8B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
68B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
37.8B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Actinium Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett